Quinaretic

FDA modified its labeling on February, 2009 to include a precaution of drug interaction with gold. "Nitritoid reactions (symptoms include facial flushing, nausea, vomiting and hypotension) have been reported rarely in patients on therapy with injectable gold (sodium aurothiomalate) and concomitant ACE inhibitor therapy including Monopril/Monopril HCT."[6] See also Perindopril/indapamide, a combination of an ACE inhibitor and a thiazide-like diuretic References .mw-parser... [wikipedia]